Your browser doesn't support javascript.
loading
SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry.
Decaesteker, Bieke; Louwagie, Amber; Loontiens, Siebe; De Vloed, Fanny; Bekaert, Sarah-Lee; Roels, Juliette; Vanhauwaert, Suzanne; De Brouwer, Sara; Sanders, Ellen; Berezovskaya, Alla; Denecker, Geertrui; D'haene, Eva; Van Haver, Stéphane; Van Loocke, Wouter; Van Dorpe, Jo; Creytens, David; Van Roy, Nadine; Pieters, Tim; Van Neste, Christophe; Fischer, Matthias; Van Vlierberghe, Pieter; Roberts, Stephen S; Schulte, Johannes; Ek, Sara; Versteeg, Rogier; Koster, Jan; van Nes, Johan; Zimmerman, Mark; De Preter, Katleen; Speleman, Frank.
Afiliação
  • Decaesteker B; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium. Bieke.Decaesteker@ugent.be.
  • Louwagie A; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium. Bieke.Decaesteker@ugent.be.
  • Loontiens S; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • De Vloed F; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Bekaert SL; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Roels J; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Vanhauwaert S; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • De Brouwer S; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Sanders E; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Berezovskaya A; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Denecker G; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • D'haene E; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Van Haver S; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Van Loocke W; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Van Dorpe J; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Creytens D; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Van Roy N; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Pieters T; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Van Neste C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
  • Fischer M; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Van Vlierberghe P; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Roberts SS; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Schulte J; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Ek S; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Versteeg R; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Koster J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
  • van Nes J; Department of Biomolecular medicine, Ghent University, Ghent, 9000, Belgium.
  • Zimmerman M; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • De Preter K; Cancer Research Institute Ghent (CRIG), Ghent, 9000, Belgium.
  • Speleman F; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
Nat Commun ; 14(1): 1267, 2023 03 07.
Article em En | MEDLINE | ID: mdl-36882421
ABSTRACT
The pediatric extra-cranial tumor neuroblastoma displays a low mutational burden while recurrent copy number alterations are present in most high-risk cases. Here, we identify SOX11 as a dependency transcription factor in adrenergic neuroblastoma based on recurrent chromosome 2p focal gains and amplifications, specific expression in the normal sympatho-adrenal lineage and adrenergic neuroblastoma, regulation by multiple adrenergic specific (super-)enhancers and strong dependency on high SOX11 expression in adrenergic neuroblastomas. SOX11 regulated direct targets include genes implicated in epigenetic control, cytoskeleton and neurodevelopment. Most notably, SOX11 controls chromatin regulatory complexes, including 10 SWI/SNF core components among which SMARCC1, SMARCA4/BRG1 and ARID1A. Additionally, the histone deacetylase HDAC2, PRC1 complex component CBX2, chromatin-modifying enzyme KDM1A/LSD1 and pioneer factor c-MYB are regulated by SOX11. Finally, SOX11 is identified as a core transcription factor of the core regulatory circuitry (CRC) in adrenergic high-risk neuroblastoma with a potential role as epigenetic master regulator upstream of the CRC.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica